Literature DB >> 12548525

Choline acetyltransferase mutations in myasthenic syndrome due to deficient acetylcholine resynthesis.

Ricardo A Maselli1, Darlene Chen, Delores Mo, Constance Bowe, Grace Fenton, Robert L Wollmann.   

Abstract

The myasthenic syndrome due to abnormal acetylcholine resynthesis is characterized by early onset, recessive inheritance, and recurrent episodes of potentially fatal apnea. Mutations in the gene encoding choline acetyltransferase (CHAT) have been found to account for this condition. We have identified five patients from three independent families with features of this disease including, in four patients, a paradoxical worsening of symptoms with cold temperatures. Electrodiagnostic studies demonstrated impaired neuromuscular transmission in all patients. In vitro microelectrode studies performed in the anconeus muscle biopsies of two patients showed moderate reduction of quantal release. Electron microscopy of the neuromuscular junction was normal in both patients. Each patient had two heterozygous CHAT mutations including L210P and P211A (family 1), V194L and V506L (family 2), and R548stop and S694C (family 3). Three of these mutations have previously been reported and suggest that, in this syndrome, some molecular defects may be more prevalent than others.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12548525     DOI: 10.1002/mus.10300

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  14 in total

1.  Choline acetyltransferase structure reveals distribution of mutations that cause motor disorders.

Authors:  Yiying Cai; Ciarán N Cronin; Andrew G Engel; Kinji Ohno; Louis B Hersh; David W Rodgers
Journal:  EMBO J       Date:  2004-05-06       Impact factor: 11.598

Review 2.  Current status of the congenital myasthenic syndromes.

Authors:  Andrew G Engel
Journal:  Neuromuscul Disord       Date:  2011-11-21       Impact factor: 4.296

Review 3.  Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment.

Authors:  Andrew G Engel; Xin-Ming Shen; Duygu Selcen; Steven M Sine
Journal:  Lancet Neurol       Date:  2015-04       Impact factor: 44.182

4.  Functional consequences and structural interpretation of mutations of human choline acetyltransferase.

Authors:  Xin-Ming Shen; Thomas O Crawford; Joan Brengman; Gyula Acsadi; Susan Iannaconne; Emin Karaca; Chaouky Khoury; Jean K Mah; Shimon Edvardson; Zeljko Bajzer; David Rodgers; Andrew G Engel
Journal:  Hum Mutat       Date:  2011-09-23       Impact factor: 4.878

5.  Choline Acetyltransferase Mutations Causing Congenital Myasthenic Syndrome: Molecular Findings and Genotype-Phenotype Correlations.

Authors:  Juan Arredondo; Marian Lara; Sídney M Gospe; Claudio G Mazia; Maria Vaccarezza; Marcela Garcia-Erro; Constance M Bowe; Celia H Chang; Michelle M Mezei; Ricardo A Maselli
Journal:  Hum Mutat       Date:  2015-07-24       Impact factor: 4.878

6.  Function of neuromuscular synapses in the zebrafish choline-acetyltransferase mutant bajan.

Authors:  Meng Wang; Hua Wen; Paul Brehm
Journal:  J Neurophysiol       Date:  2008-08-06       Impact factor: 2.714

7.  Lethal impairment of cholinergic neurotransmission in hemicholinium-3-sensitive choline transporter knockout mice.

Authors:  Shawn M Ferguson; Mihaela Bazalakova; Valentina Savchenko; Juan Carlos Tapia; Jane Wright; Randy D Blakely
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-01       Impact factor: 11.205

Review 8.  What have we learned from the congenital myasthenic syndromes.

Authors:  Andrew G Engel; Xin-Ming Shen; Duygu Selcen; Steven M Sine
Journal:  J Mol Neurosci       Date:  2009-08-18       Impact factor: 3.444

9.  Expression of choline acetyltransferase in rat spinal motoneurons after antiorthostatic suspension.

Authors:  R R Islamov; O V Tyapkina; E A Bukharaeva; L O Yagodina; N N Ibragimova; V V Valiullina; I B Kozlovskaya; E E Nikolsky
Journal:  Dokl Biol Sci       Date:  2007 May-Jun

10.  Chaperone-Mediated Regulation of Choline Acetyltransferase Protein Stability and Activity by HSC/HSP70, HSP90, and p97/VCP.

Authors:  Trevor M Morey; Warren Winick-Ng; Claudia Seah; R Jane Rylett
Journal:  Front Mol Neurosci       Date:  2017-12-12       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.